nach oben

Erschienen in:

01.06.2019 | Case report

Bevacizumab

Rectovaginal fistula and genitourinary fistula: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective study of female patients treated at Seoul National University Hospital between April 2014 and February 2018, two women [ages not stated] were described who developed rectovaginal fistula or genitourinary fistula following treatment with bevacizumab [routes, time to reactions onsets and outcomes not stated]. The women with cervical cancer started receiving bevacizumab 15 mg/kg on day 1, paclitaxel and cisplatin, every three weeks. Subsequently, they developed rectovaginal fistula and genitourinary fistula (one patient each) …

Lee N, et al. Bevacizumab efficacy and recurrence pattern of persistent and metastatic cervical cancer. In Vivo 33: 863-868, No. 3, Jun 2019. Available from: URL: http://doi.org/10.21873/invivo.11551 - South Korea

Titel: Bevacizumab
Rectovaginal fistula and genitourinary fistula: 2 case reports
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63623-6

Springer Medizin

Bevacizumab

Rectovaginal fistula and genitourinary fistula: 2 case reports

Excerpt

Weitere Artikel der Ausgabe 1/2019

Eculizumab

Amiodarone/ciclosporin

Anlotinib

Domperidone

Ciclosporin

Olanzapine

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Eculizumab

Amiodarone/ciclosporin

Anlotinib

Domperidone

Ciclosporin

Olanzapine